English prostate cancer visit feedback tool for shared decisions
Part of Cancer, Kidney & urinary clinical trials.
This trial tests an English computer tool that gives feedback during prostate cancer treatment visits. It aims to help you and your clinician make more informed, shared decisions about next treatment steps.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man starting a prostate cancer treatment discussion for the first time.
- Your prostate cancer is still localized (not locally advanced and not metastatic).
- You are a Cedars-Sinai patient.
- You can read and write in English.
- You have not already had treatment for localized prostate cancer.
- You do not have major trouble communicating or dementia.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a computer tool that analyzes your conversations with doctors. It aims to help you make a more informed choice about prostate cancer treatment.
This study is testing an AI tool that helps explain prostate biopsy results in a way that is easier to understand. If you join, you'll review your pathology report with the help of this tool to see if it improves your understanding of your diagnosis.
This study tests a digital support tool that helps you understand your prostate cancer diagnosis and treatment options. It uses artificial intelligence to guide you through educational materials and connect you with support resources.
This trial tests an English decision aid (a patient guide) to help older men understand and feel comfortable with “active surveillance” for localized prostate cancer. It also checks how easy to use it is for patients, caregivers, and prostate cancer clinicians.
This study tests a digital tool called MyCareGorithm that helps patients understand their cancer treatment plans. It is for people with head and neck or prostate cancer, their caregivers, and their doctors.
This study tests a digital tool to help men with early prostate cancer make treatment decisions. It aims to see if the tool improves communication and support during this stressful time.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.